ANAVEX LIFE SCIENCES CORP. Quarterly Earnings Per Share, Diluted in USD/shares from Q2 2010 to Q2 2025

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.
Summary
Anavex Life Sciences Corp. quarterly/annual Earnings Per Share, Diluted history and growth rate from Q2 2010 to Q2 2025.
  • Anavex Life Sciences Corp. Earnings Per Share, Diluted for the quarter ending June 30, 2025 was -0.16 USD/shares, a 14.3% decline year-over-year.
  • Anavex Life Sciences Corp. Earnings Per Share, Diluted for the twelve months ending June 30, 2025 was 0 USD/shares, a 14% decline year-over-year.
  • Anavex Life Sciences Corp. annual Earnings Per Share, Diluted for 2024 was -0.52 USD/shares, a 13.3% increase from 2023.
  • Anavex Life Sciences Corp. annual Earnings Per Share, Diluted for 2023 was -0.6 USD/shares, a 3.23% increase from 2022.
  • Anavex Life Sciences Corp. annual Earnings Per Share, Diluted for 2022 was -0.62 USD/shares, a 14.8% decline from 2021.
Earnings Per Share, Diluted, Trailing 12 Months (USD/shares)
Earnings Per Share, Diluted, Quarterly (USD/shares)
Earnings Per Share, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 $0 $0 $0 -14.3% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-12
Q1 2025 $0 $0 $0 0% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-13
Q4 2024 $0 $0 $0 -27.3% Oct 1, 2024 Dec 31, 2024 10-Q 2025-02-12
Q3 2024 $0 $0 $0 -16.7% Jul 1, 2024 Sep 30, 2024 10-K 2024-12-23
Q2 2024 $0 $0 $0 0% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-12
Q1 2024 $0 $0 +$0.04 +23.5% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-13
Q4 2023 $0 $0 +$0.06 +35.3% Oct 1, 2023 Dec 31, 2023 10-Q 2025-02-12
Q3 2023 $0 $0 Jul 1, 2023 Sep 30, 2023 10-K 2024-12-23
Q2 2023 $0 Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $0 Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $0 Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-07
Q1 2017 $0 $0 +$0.02 +33.3% Jan 1, 2017 Mar 31, 2017 10-Q 2017-05-10
Q4 2016 $0 $0 +$0.04 +33.3% Oct 1, 2016 Dec 31, 2016 10-Q 2017-02-07
Q3 2016 $0 $0 +$0.07 +28% Jul 1, 2016 Sep 30, 2016 10-K 2016-12-14
Q2 2016 $0 $0 +$0.16 +72.7% Apr 1, 2016 Jun 30, 2016 10-Q 2016-08-11
Q1 2016 $0 $0 +$0.06 +50% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 $0 $0 $0 -100% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-07
Q3 2015 $0 $0 +$0.70 +73.7% Jul 1, 2015 Sep 30, 2015 10-K 2016-12-14
Q2 2015 -$1 $0 $0 -633% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
Q1 2015 -$1 $0 $0 -300% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-11
Q4 2014 -$1 $0 $0 -500% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-08
Q3 2014 -$1 -$1 -$1 -850% Jul 1, 2014 Sep 30, 2014 10-K 2016-12-14
Q2 2014 $0 $0 $0 -200% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-14
Q1 2014 $0 $0 $0 Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q4 2013 $0 $0 $0 0% Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-17
Q3 2013 $0 $0 $0 -400% Jul 1, 2013 Sep 30, 2013 10-K 2014-12-29
Q2 2013 $0 $0 +$0.15 +93.8% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-13
Q1 2013 $0 $0 +$0.03 Jan 1, 2013 Mar 31, 2013 10-Q/A 2014-05-30
Q4 2012 $0 $0 +$0.07 +87.5% Oct 1, 2012 Dec 31, 2012 10-Q 2014-02-14
Q3 2012 $0 $0 +$0.05 +71.4% Jul 1, 2012 Sep 30, 2012 10-K 2013-12-30
Q2 2012 $0 $0 $0 -167% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 $0 $0 +$0.05 +62.5% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-17
Q4 2011 $0 $0 $0 0% Oct 1, 2011 Dec 31, 2011 10-Q 2013-02-14
Q3 2011 $0 $0 Jul 1, 2011 Sep 30, 2011 10-K 2012-12-31
Q2 2011 $0 +$0.03 +33.3% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-17
Q1 2011 $0 Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
Q4 2010 $0 Oct 1, 2010 Dec 31, 2010 10-Q 2012-02-14
Q2 2010 $0 Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.